G1 Therapeutics Announces Initiation of Phase 1b/2 Clinical Trial of G1T38 in Combination with Tagrisso for EGFR-Mutant Non-Small Cell Lung Cancer
Pharmaceutical Investing Corvus Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results
Biotech Investing Iovance Biotherapeutics Announces Closing of $172.5 Million Common Stock Public Offering
Biotech Investing Helix Announces Peer-Review Publication of V-DOS47 in Frontiers in Immunology Journal
Biotech Investing Heat Biologics Presents Immune Data on its HS-410 Phase 2 Bladder Cancer Trial at the Genitourinary Cancers Symposium
Biotech Investing Champions Oncology Announces New Collection of Patient-Derived Xenograft (PDX) Models Available for Translational Research
Biotech Investing Gradalis, Inc. Announces Initiation of a Phase 2 Study using Gradalis’ Vigil® Immunotherapy in Combination with Anti-PD-1 Technology to Treat Patients with Advanced Non-Small Cell Lung Cancer